Ingevity (NYSE: NGVT) legal chief Ryan Fisher sells 2,709 shares

Rhea-AI Filing Summary

Ingevity Corp executive Ryan C. Fisher, SVP, General Counsel & Secretary, reported selling a total of 2,709 shares of common stock on August 3, 2026. The sales occurred in two non-derivative transactions classified as sales in open market or private transactions at $73.7600 and $73.6700 per share. The Rule 10b5-1 trading plan checkbox was not checked for these trades.

Insider Trade Summary

Net Seller: 2,709 shares

Net Sell 2 txns

Insider Fisher Ryan C.

Role SVP, Gen. Counsel & Secretary

Sold 2,709 shs ($200K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,397	$73.76	$103K
Sale	Common Stock	1,312	$73.67	$97K

Holdings After Transaction: Common Stock — 15,722 shares (Direct)

Key Figures

Total shares sold: 2709 shares First sale: 1397.0000 shares at $73.7600 per share Second sale: 1312.0000 shares at $73.6700 per share +1 more

4 metrics

Total shares sold 2709 shares Aggregate common shares sold by Ryan C. Fisher on August 3, 2026

First sale 1397.0000 shares at $73.7600 per share Non-derivative common stock sale on August 3, 2026

Second sale 1312.0000 shares at $73.6700 per share Non-derivative common stock sale on August 3, 2026

Number of sale transactions 2 Non-derivative sales of Ingevity common stock reported for August 3, 2026

Key Terms

open market or private transaction, Rule 10b5-1, non-derivative

3 terms

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

Rule 10b5-1 regulatory

"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

non-derivative financial

"transaction_type: non-derivative common stock transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 05:14 PM Accepted by SEC EDGAR 08/04/2026 - 05:14 PM Learn about SEC filing dates

FAQ

What insider stock transaction did Ingevity (NGVT) report for Ryan C. Fisher?

Ingevity reported that Ryan C. Fisher, its SVP, General Counsel & Secretary, sold 2,709 shares of Ingevity common stock on August 3, 2026 in two non-derivative transactions classified as sales in open market or private transactions.

How many Ingevity (NGVT) shares did Ryan C. Fisher sell, and on what date?

Ryan C. Fisher sold a total of 2,709 shares of Ingevity common stock on August 3, 2026. The activity was reported in two separate non-derivative transactions on the same date, both involving Ingevity common stock.

At what prices were the Ingevity (NGVT) shares sold by Ryan C. Fisher?

Fisher’s reported sales occurred at $73.7600 per share for 1,397.0000 shares and $73.6700 per share for 1,312.0000 shares. Both transactions were classified as sales in open market or private transactions on August 3, 2026.

Were Ryan C. Fisher’s Ingevity (NGVT) stock sales under a Rule 10b5-1 plan?

The filing shows the Rule 10b5-1 checkbox was not checked, so these transactions were not affirmed as being conducted under a Rule 10b5-1 trading plan based on the reported data field aff_10b5_one being false.

Were the Ingevity (NGVT) insider transactions by Ryan C. Fisher derivative or non-derivative?

Both reported transactions are labeled as non-derivative and involve Ingevity common stock. No derivative securities (such as options or warrants) were reported in these specific entries, and the derivativeSummary section for this filing is empty.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher Ryan C.

(Last) (First) (Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON SOUTH CAROLINA 29405

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Gen. Counsel & Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/03/2026		S		1,397	D	$73.76	17,034	D
Common Stock	08/03/2026		S		1,312	D	$73.67	15,722	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Ryan C. Fisher By: Mavis Huger as Attorney-in-Fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)